Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Staphylococci.

A L Casey1, P A Lambert, T S J Elliott

  • 1Department of Clinical Microbiology and Infection Control, University Hospital Birmingham NHS Foundation Trust, The Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK.

International Journal of Antimicrobial Agents
|August 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A study on the prevalence of cyathostomin and Anoplocephala perfoliata infections in Italian horses: diagnostic testing and analysis of factors affecting infection risk.

Journal of equine veterinary science·2026
Same author

Deployment of whole genome next-generation sequencing of SARS-CoV-2 in a military maritime setting.

BMJ military health·2023
Same author

The drugs don't work: evaluation of educational theatre to gauge and influence public opinion on antimicrobial resistance.

The Journal of hospital infection·2019
Same author

Use of a saliva-based diagnostic test to identify tapeworm infection in horses in the UK.

Equine veterinary journal·2017
Same author

Skin antisepsis: it's not only what you use, it's the way that you use it.

The Journal of hospital infection·2017
Same author

Enhanced chlorhexidine skin penetration with 1,8-cineole.

BMC infectious diseases·2017
Same journal

Machine Learning-Based Drug Susceptibility Prediction from Candida Genomic Data.

International journal of antimicrobial agents·2026
Same journal

Vancomycin Penetration into Intra-abdominal Compartments: Site Concentration Disparities and Implications for Dose Optimization in Gram-Positive Infections.

International journal of antimicrobial agents·2026
Same journal

Strain-dependent variability in pharmacodynamic interactions for phage-antibiotic combinations in Pseudomonas aeruginosa.

International journal of antimicrobial agents·2026
Same journal

Carbapenem-resistant Enterobacterales across the UK: a nationwide study of carbapenemase testing and novel antimicrobial activity.

International journal of antimicrobial agents·2026
Same journal

Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime.

International journal of antimicrobial agents·2026
Same journal

Ceftaroline pharmacokinetics on ECMO, a pediatric case report.

International journal of antimicrobial agents·2026
See all related articles

Staphylococci cause many hospital infections, and resistance to common antibiotics like beta-lactams and glycopeptides is increasing. This review discusses current and future Staphylococcus treatment options.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Staphylococci are a major cause of nosocomial infections.
  • Increasing antimicrobial resistance to beta-lactams and glycopeptides complicates treatment.
  • Effective therapeutic strategies are crucial for managing staphylococcal infections.

Purpose of the Study:

  • To review the current therapeutic landscape for staphylococcal infections.
  • To explore future perspectives in the treatment of Staphylococcus aureus and coagulase-negative staphylococci infections.
  • To address the challenge of antimicrobial resistance in staphylococci.

Main Methods:

  • Literature review of current research and clinical studies.
  • Analysis of antimicrobial susceptibility patterns.

Related Experiment Videos

  • Evaluation of existing and emerging therapeutic agents.
  • Discussion of treatment guidelines and challenges.

    • Main Results:

    • Staphylococcal infections remain a significant clinical challenge.
    • Resistance to beta-lactams and glycopeptides is a growing concern.
    • A variety of therapeutic options exist, but novel approaches are needed.
    • Emerging therapies show promise for combating resistant strains.

    Conclusions:

    • Effective management of staphylococcal infections requires a multifaceted approach.
    • Continued research into new antimicrobial agents and treatment strategies is essential.
    • Addressing antimicrobial resistance is critical for improving patient outcomes.